Prof. Ki Tae Suk | Web-Literature |Best Researcher Award
Prof. Ki Tae Suk is a distinguished figure in the field of medicine and academia, known for his unwavering dedication and exceptional contributions. Graduating with a Medical Degree from Yonsei University’s Wonju College of Medicine in 1999, he embarked on a journey of relentless pursuit of knowledge and specialization. His quest for excellence led him to pursue a Master of Medicine at Yonsei University’s Graduate School in Seoul from 2003 to 2015, where he honed his expertise. In 2010, he reached the pinnacle of medical education, obtaining a Doctor of Medicine degree from Yonsei University. Eager to expand his horizons and delve into groundbreaking research, he undertook a post-Doctor Research Scholar position in Medicine at Columbia University in New York, USA, from 2014 to 2016. Armed with a wealth of experience and knowledge garnered from his diverse academic journey, Prof. Ki Tae Suk returned to Korea, assuming the esteemed role of Professor at Hallym University in Chuncheon in September 2016. His illustrious career is characterized by a steadfast commitment to excellence, perseverance, and a passion
🎓 Education:
🎓 After obtaining a Medical Degree from Yonsei University’s Wonju College of Medicine in 1999, I embarked on a journey of continuous learning and specialization. From 2003 to 2015, I pursued a Master of Medicine at Yonsei University’s Graduate School in Seoul, further honing my expertise. In 2010, I achieved the pinnacle of medical education, earning a Doctor of Medicine degree from Yonsei University. Seeking to broaden my horizons and delve into cutting-edge research, I ventured to Columbia University in New York, USA, where I served as a post-Doctor Research Scholar in Medicine from 2014 to 2016. Armed with a wealth of experience and knowledge, I returned to Korea and assumed the role of Professor at Hallym University in Chuncheon from September 2016 onwards. 🌟 My journey in academia and medicine has been marked by dedication, perseverance, and a relentless pursuit of excellence.
Research Interests :
🩺 Exploring the intricate interplay between liver disease and the microbiota opens a gateway to understanding and managing conditions like cirrhosis and hepatocellular carcinoma. The role of microbiota-derived metabolites and their impact on liver health, alongside the concept of post-biotics, emerges as pivotal in this realm. 🦠 Unraveling the multi-omics associated mechanisms sheds light on the complex pathways underlying liver disease progression and offers new avenues for therapeutic intervention. Enter pharmabiotics, where the convergence of pharmaceuticals and probiotics holds promise for innovative therapeutics and diagnostic markers, aiming to target liver diseases at their root cause. 🧬 This holistic approach, leveraging insights from microbiome research, paves the way for personalized medicine and enhanced patient outcomes in the realm of liver disease management.
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
Citation : 3
Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy